CNS Demyelinating Disease Evaluation

This contract involves performing laboratory evaluations focused on cerebrospinal fluid (CSF) and serum biomarkers, such as oligoclonal bands and IgG index, which are critical for diagnosing multiple sclerosis (MS) and other demyelinating diseases. The work falls under the NAICS code 621511, indicating medical laboratories, and is issued by the Department of Veterans Affairs through the 257-NETWORK Contract Office 17. The contract is structured as a subcontract and does not specify set-aside requirements or detailed location data for the place of performance. The contract was posted on June 5, 2026, with a response deadline set for June 10, 2026, indicating a short timeframe for submissions. While some organizational and contact details are not provided, it is clear that this opportunity is geared toward entities capable of providing specialized laboratory testing services that support accurate diagnosis and management of CNS demyelinating conditions, which are especially relevant to veteran healthcare populations. The provided link directs interested parties to the official SAM.gov workspace to access additional information and submit responses.